World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
28650
World Ranking
16489
National Ranking
1507

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Surgery

His primary areas of study are Physical therapy, Rheumatoid arthritis, Internal medicine, Rheumatology and MEDLINE. John R. Kirwan has included themes like Osteoarthritis, Clinical trial, Patient satisfaction and Psychological intervention in his Physical therapy study. His research in Rheumatoid arthritis intersects with topics in Inflammation, Severity of illness, Health assessment and Arthritis.

His Internal medicine research is multidisciplinary, incorporating perspectives in Placebo and Surgery. His Rheumatology research incorporates themes from Alternative medicine, Necrosis, Family medicine and Health professionals. He interconnects Rheumatism and Evidence-based practice in the investigation of issues within MEDLINE.

His most cited work include:

  • American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials (993 citations)
  • Recommendations for a core set of outcome measures for future Phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III (634 citations)
  • Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0 (484 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Rheumatoid arthritis, Physical therapy, Internal medicine, Rheumatology and Clinical trial. His Rheumatoid arthritis study incorporates themes from Prednisolone, Glucocorticoid, Disease and Arthritis. His work carried out in the field of Physical therapy brings together such families of science as Osteoarthritis, Alternative medicine, Patient satisfaction, MEDLINE and Randomized controlled trial.

His Osteoarthritis study combines topics in areas such as Knee Joint and Radiography. His work deals with themes such as Endocrinology and Surgery, which intersect with Internal medicine. John R. Kirwan regularly ties together related areas like Severity of illness in his Clinical trial studies.

He most often published in these fields:

  • Rheumatoid arthritis (45.93%)
  • Physical therapy (40.74%)
  • Internal medicine (34.57%)

What were the highlights of his more recent work (between 2012-2020)?

  • Physical therapy (40.74%)
  • Rheumatoid arthritis (45.93%)
  • Internal medicine (34.57%)

In recent papers he was focusing on the following fields of study:

John R. Kirwan mostly deals with Physical therapy, Rheumatoid arthritis, Internal medicine, Rheumatology and Randomized controlled trial. The various areas that he examines in his Physical therapy study include Psychological intervention, Self-management, Clinical trial, Arthritis and Intervention. His study in Clinical trial is interdisciplinary in nature, drawing from both Visual analogue scale, Context, Family medicine and Scope.

The Rheumatoid arthritis study combines topics in areas such as Alternative medicine, Disease, Coping, Clinical psychology and Prednisone. His Internal medicine study integrates concerns from other disciplines, such as Immunology and Outcomes research. His work in Randomized controlled trial tackles topics such as Mood which are related to areas like Feeling.

Between 2012 and 2020, his most popular works were:

  • Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0 (484 citations)
  • EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases (158 citations)
  • Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2) (118 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Surgery

His main research concerns Physical therapy, Internal medicine, Rheumatology, Outcome and Medical education. His Physical therapy research is multidisciplinary, incorporating elements of Clinical trial, Quality of life, Systematic review, Rheumatoid arthritis and Severity of illness. His Rheumatoid arthritis research includes elements of Rating scale, Disease, Coping and Outcomes research.

His study in Morning and Prednisone is carried out as part of his studies in Internal medicine. John R. Kirwan combines subjects such as Osteoarthritis, Context, Randomized controlled trial, Intention-to-treat analysis and Visual analogue scale with his study of Rheumatology. His studies in Medical education integrate themes in fields like Alternative medicine, Patient participation and Moderation.

Best Publications

  • American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang

  • Recommendations for a core set of outcome measures for future Phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III

    Nicholas Bellamy;John Kirwan;Maarten Boers;Peter Brooks

  • Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

    Maarten Boers;John R. Kirwan;George Wells;Dorcas Beaton

  • Determinants of disability in osteoarthritis of the knee.

    T. E. M. Mcalindon;C. Cooper;J. R. Kirwan;P. A. Dieppe

  • STANFORD HEALTH ASSESSMENT QUESTIONNAIRE MODIFIED TO ASSESS DISABILITY IN BRITISH PATIENTS WITH RHEUMATOID ARTHRITIS

    J. R. Kirwan;Jane S. Reeback

  • Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology

    F. Buttgereit;J.A. da Silva;M. Boers;G.R. Burmester

  • Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data

    J A P Da Silva;J W G Jacobs;J R Kirwan;M Boers

  • Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy.

    Paul Dieppe;Janet Cushnaghan;Philip Young;John Kirwan

  • EULAR evidence based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

    J. N. Hoes;J. W. G. Jacobs;M. Boers;D. Boumpas

  • Effects of glucocorticoids on radiological progression in rheumatoid arthritis.

    John R Kirwan;Johannes Wj Bijlsma;Maarten Boers;Beverley Shea

  • Patient education for adults with rheumatoid arthritis

    Robert P Riemsma;John R Kirwan;Erik Taal;Hans Jj Rasker

  • Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis.

    John R Kirwan;Patricia Minnock;Ade Adebajo;Barry Bresnihan

  • Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative

    L Gossec;S Paternotte;G J Aanerud;A Balanescu

  • Rheumatology outcomes: the patient's perspective.

    Alison Carr;Sarah Hewlett;Rod Hughes;Helene Mitchell

  • KNEE PAIN AND DISABILITY IN THE COMMUNITY

    T. E. McALINDON;C. Cooper;J. R. Kirwan;P. A. Dieppe

  • Non-pharmacological interventions for fatigue in rheumatoid arthritis

    Fiona Cramp;Sarah Hewlett;Celia Almeida;John R Kirwan

  • Patients and professionals as research partners: challenges, practicalities, and benefits.

    Sarah Hewlett;Marteen de Wit;Pam Richards;Enid Quest

  • EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases

    N Duru;M C van der Goes;J W G Jacobs;Tara Andrews

  • Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group.

    P Hickling;R K Jacoby;J R Kirwan

  • Quality of life measures

    A. J. Carr;P. W. Thompson;J. R. Kirwan

Frequent Co-Authors

Maarten Boers
Maarten Boers Vrije Universiteit Amsterdam
Peter Tugwell
Peter Tugwell University of Ottawa
Ernest Choy
Ernest Choy Cardiff University
Laure Gossec
Laure Gossec Sorbonne University
George A. Wells
George A. Wells University of Ottawa
Vibeke Strand
Vibeke Strand Stanford University
Peter Brooks
Peter Brooks University of Melbourne
Paul Dieppe
Paul Dieppe University of Exeter
Clifton O. Bingham
Clifton O. Bingham Johns Hopkins University
Maxime Dougados
Maxime Dougados Hôpital Cochin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees in healthcare can open the door to a rewarding medical career, offering flexibility and affordability. Many students start by completing the cheapest online nursing program to earn essential credentials without incurring hefty debt. These programs offer a strong foundation in patient care and make it easier to start working while studying further.

For those aiming to advance their careers, there are flexible pathways to higher degrees. Many working nurses consider earning a phd in nursing online programs to move into leadership, research, or education roles.

Registered nurses looking to upgrade their qualifications can review the average cost of rn to bsn programs online. These programs often suit working professionals and help open up doors to more specialized positions.

If you have a non-nursing bachelor’s degree but wish to enter the nursing field quickly, consider direct entry nurse practitioner programs for non-nurses online. These accelerated programs can fast-track your journey to becoming a nurse practitioner, expanding your career options and impact in healthcare.

Best Scientists Citing John R. Kirwan

Trending Scientists